Clinical Trial

Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

Name: Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol — clinical trial record (NCT07308717)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This study aims to assess whether gabapentin should be a standard component of peri-operative pain control in mastectomy patients at Memorial Sloan Kettering Cancer Center.

Trial Details

NCT Number	NCT07308717
Lead Sponsor	Memorial Sloan Kettering Cancer Center
Conditions	Breast Cancer
Enrollment	1,896 participants
Start Date	2025-12-16
Primary Completion	2027-12-16 (estimated)
Study Completion	2027-12-16 (estimated)
Updated on ClinicalTrials.gov	2025-12-30